Beta Blockers and Chronic Obstructive Pulmonary Disease (COPD): Sum of Evidence.
Curr Hypertens Rev
; 17(3): 196-206, 2021.
Article
de En
| MEDLINE
| ID: mdl-33302840
Approximately half a century has passed since the discovery of beta-blockers. Then, their prime therapeutic purpose was to treat angina and cardiac arrhythmias; nowadays, beta-blockers' usage and effectiveness are extended to treat other cardiovascular diseases, such as hypertension, congestive heart failure, and coronary artery disease. Safety concerns were raised about beta- blockers and their use for chronic obstructive pulmonary disease (COPD) patients with concurrent cardiovascular disease. After thorough research of the literature, this review summarizes the evidence proving that beta-blockers not only might be well tolerated in COPD patients, but they might also have a beneficial effect in this group of patients.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
Maladies cardiovasculaires
/
Broncho-pneumopathie chronique obstructive
/
Défaillance cardiaque
Type d'étude:
Diagnostic_studies
Limites:
Humans
Langue:
En
Journal:
Curr Hypertens Rev
Année:
2021
Type de document:
Article
Pays d'affiliation:
Grèce
Pays de publication:
Émirats arabes unis